ELZA’s team members are very involved in both clinical and basic research. ELZA follows the American model, in which advances in medicine do not necessarily always have to come from a university. Even small and innovative so-called “think tanks” can serve as incubators for translational research.
Patients can benefit from physicians who not only know and use the latest medical technology, but have helped to develop them – and therefore have a deeper understanding of them.
- Publication of several high impact publications, among others in Nature Medicine and Nature Genetics.
- Molecular mechanisms of retinal degeneration.
- Better understanding the mechanisms of wound healing of the cornea after refractive laser surgery.
- Improving cross-linking technology.
- Keratoconus and corneal biomechanics.
- Further developing PACK-CXL for treating corneal infections.
- Improvement of ablation algorithms in refractive laser surgery.
- Complications managment: the establishment of new techniques for the correction of complications after refractive laser surgery.
- Improvement of the corneal cross-linking technique for the treatment of progressive keratoconus, postoperative keratectasia, melting corneal processes and corneal dystrophies.